Interact to see
Advertisement
Advertisement
ECDCX vs MEDAX
ECDCX vs MEDAX Comparison
Open Charts ECDCX vs MEDAX
Ashmore Emerging Mkts Corp Inc C
Price$5.45
Change-$0.01 (-0.18%)
VolumeN/A
Net Assets20.44M
MFS Emerging Markets Debt A
Price$12.18
Change-$0.03 (-0.25%)
VolumeN/A
Net Assets7.29B
ECDCX vs MEDAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ECDCX vs. MEDAX commentary
Jul 12, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECDCX is a Sell and MEDAX is a Hold.
FUNDAMENTALS
Fundamentals
MEDAX has more cash in the bank: 7.29B vs. ECDCX (20.4M). MEDAX pays higher dividends than ECDCX: MEDAX (5.81) vs ECDCX (4.95). ECDCX was incepted earlier than MEDAX: ECDCX (14 years) vs MEDAX (27 years). ECDCX (2.43) is less costly to investors than MEDAX (1.07). ECDCX is a more actively managed with annual turnover of: 95.00 vs. MEDAX (58.00). ECDCX (1000) and MEDAX (1000) have matching initial minimum investment requirements. MEDAX annual gain was more profitable for investors over the last year : 7.38 vs. ECDCX (5.27). MEDAX return over 5 years is better than : 10.43 vs. ECDCX (-2.70).
| ECDCX | MEDAX | ECDCX / MEDAX | |
| Total Expense Ratio | 1.94 | 1.06 | 183% |
| Annual Report Gross Expense Ratio | 2.43 | 1.07 | 227% |
| Fund Existence | 14 years | 27 years | - |
| Gain YTD | 2.749 | 4.487 | 61% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 20.4M | 7.29B | 0% |
| Annual Yield % from dividends | 4.95 | 5.81 | 85% |
| Returns for 1 year | 5.27 | 7.38 | 71% |
| Returns for 3 years | 21.30 | 30.59 | 70% |
| Returns for 5 years | -2.70 | 10.43 | -26% |
| Returns for 10 years | 19.09 | 37.32 | 51% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement